HR Execs on the Move

Sensiotec

www.sensiotec.com

 
Sensiotec Inc., a medical device company, designs and delivers non-contact remote vital signs monitoring solutions in the United States. The company offers Virtual Medical Assistant that monitors patients, supporting evidenced-based medicine; and monitors heart and respiration rates and movement without pressure pads, sensors, or cuffs that touch the patient. The company serves acute and subacute care facilities, which include hospitals, surgery centers, outpatient clinics, skilled nursing, long-term care and hospice facilities. Sensiotec Inc. was founded in 2008 and is based in Atlanta, Georgia.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Tobii Dynavox

Tobii Dynavox, a wholly owned subsidiary of Tobii AB (publ), is the leading global provider of eye tracking enabled and touch-based augmented and alternative communication (AAC) devices as well as symbol-based products for individuals with special needs.

HomeCare Connect

HomeCare Connect is a privately held company with a single-minded mission. We strive to provide the highest quality and most responsive home care services for our clients, which are workers’ compensation and auto liability insurance companies, employers and other payers. Based in the Orlando, Florida area, we serve clients nationally with a comprehensive range of home health care services, durable medical equipment and medical supplies. We have a clinically driven model — from our 15,000+ credentialed provider network to our highly experienced clinical staff who coordinate everything related to care, medical supplies and equipment delivered in the home. We make sure the injured worker receives the right care, equipment and supplies from the right providers at the right time.

Access Ingenuity

Access Ingenuity is a Santa Rosa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Syntheon, Endoscopy Division

Syntheon, Endoscopy Division is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viz

In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.